Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp149 | Male Reproduction and Endocrine Disruptors | ECE2017

Presentation, clinical features and long-term follow-up of Leydig cell tumours of the testis: 77 cases from a single center experience

Isidori Andrea M. , Giannetta Vincenzo , Gianfrilli Daniele , Lauretta Rosa , Tarsitano Maria Grazia , Fattorini Giorgio , Pofi Riccardo , Pozza Carlotta , Lenzi Andrea

Introduction: With the improved imaging techniques, Leydig cell tumours (LCTs) are frequently found, accounting up to 22% of testicular tumours. The natural history of LCTs is relatively unknown, because of the small size and heterogeneity of available studies. Since LCTs are often removed, long-term follow-up is missing. The aim of this study was to report the experience with a large cohort of prospectively collected LCTs.Materials and methods: Patients...

ea0049ep1050 | Pituitary - Clinical | ECE2017

Effects of somatostatin analogs on glucose metabolism in acromegalic patients: a meta-analysis of prospective interventional studies

Feola Tiziana , Cozzolino Alessia , Simonelli Ilaria , Sbardella Emilia , Puliani Giulia , Giannetta Elisa , Pasqualetti Patrizio , Lenzi Andrea , Isidori Andrea M

Introduction: Glucose metabolism impairment is a common complication of acromegaly. Somatostatin analogs (SSAs) are used as both first and second line treatment. The effect of SSAs on glucose metabolism in acromegaly is still debated.Aim: To address the following questions: 1) do SSAs affect glucose metabolism? 2) does the effect correlate with disease control? 3) do different SSAs – Lanreotide (LAN) and octreotide LAR (OCT) – affect metabolism...

ea0049ep1054 | Pituitary - Clinical | ECE2017

Quantitative analysis of the pituitary gland at magnetic resonance imaging in obese patients

Puliani Giulia , Lubrano Carla , Fiorelli Marco , Sbardella Emilia , Graziadio Chiara , Gianfrilli Daniele , Lenzi Andrea , Isidori Andrea M

Background: Hypothalamic-pituitary function and adipose tissue are deeply interconnected. Obesity has been linked to morpho-functional changes in several endocrine glands (thyroid, adrenal, gonads). No study has quantified the appearance of the pituitary gland in obese subjects.Aim: To measure pituitary signal intensity, homogeneity and texture of the pituitary gland at magnetic resonance (MR) in obese subjects free of focal pituitary disease.<p clas...

ea0037ep973 | Thyroid (non-cancer) | ECE2015

Morphological and functional alterations of thyroid gland during treatment with tyrosine kinase inhibitors in advanced renal cell carcinoma

Rizza Laura , Giannetta Elisa , Sbardella Emilia , Lauretta Rosa , Gianfrilli Daniele , Lenzi Andrea , Longo Flavia , Isidori Andrea M

Background: Sunitinib (SUN) is a novel oral multitarget tyrosine-kinase inhibitor (TKI) that has demonstrated its efficacy in the treatment of metastatic renal cell carcinoma (mRCC). The thyroid dysfunction is one of the most common side effects of SUN. The mechanisms inducing thyroid dysfunction are still poorly understood.Aim: Identify the incidence, severity, ultrasonographic changes and pattern of response of thyroid function tests during treatment w...

ea0035p955 | Steroid metabolism and action | ECE2014

Testosterone supplementation and sexual function: a meta-analysis study

Corona Giovanni , Isidori Andrea M , Buvat Jaques , Aversa Antonio , Ratrelli Giulia , Hackett Geoff , Rochira Vincenzo , Lenzi Andrea , Maggi Mario

Introduction: The role of testosterone supplementation (TS) as a possible treatment for male sexual dysfunction remains questionable. The aim of the present study is to meta-analyse data evaluating the effects of TS on male sexual function and its therapeutic synergism with the use of phosphodiesterase type 5 (PDE5i).Methods: An extensive Medline Embase and Cochrane search was performed including the following words: ‘testosterone’, ‘erect...

ea0070aep528 | Endocrine-related Cancer | ECE2020

Sarcopenia can predict response to therapy in NSCLC patients treated with PD-1 inhibitors: A longitudinal prospective study.

Tenuta Marta , Sbardella Emilia , Pandozzi Carla , Gelibter Alain J. , Sirgiovanni Grazia , Giannetta Elisa , Pozza Carlotta , Lenzi Andrea , Isidori Andrea

Introduction: Immune checkpoint inhibitors (ICI) show promising efficacy in the treatment of a wide range of advanced cancers, butlong-term response is currently limited to a subset of patients. Sarcopenia is a condition characterized by loss of skeletal muscle mass and decreased muscle function which occurs in approximately 50% of advanced cancer patients,related to malnutrition, inflammation, and treatments.Objective: The aim of this prospective o...

ea0016p203 | Diabetes and cardiovascular diseases | ECE2008

Effects of testosterone and sildenafil on cytokines and angiogenic factors: a randomized controlled trial

Isidori Andrea M , Aversa Antonio , Pozza Carlotta , Giannetta Elisa , Spera Gianni , Bonifacio Vincenzo , Fabbri Andrea , Lenzi Andrea

Ageing in men is accompanied by a decline in serum testosterone (T) levels and increased risk of cardiovascular disease, osteopenia, visceral obesity and impaired metabolism. These conditions have complex aetiologies that may share a common pro-inflammatory state. We investigated the impact of T therapy on cytokines and angiogenic factors involved in atherosclerosis and bone loss, in hypogonadal men who underwent androgen replacement. We carried out a 6 months, randomized, dou...

ea0075a10 | Adrenal gland | EYES2021

Impact of adrenalectomy on cardiovascular features in patients with adrenal incidentalomas and possible autonomous cortisol secretion: Results from ITACA study

Minnetti Marianna , Bonaventura Ilaria , Angelini Francesco , Sbardella Emilia , Pofi Riccardo , Cozzolino Alessia , Gianfrilli Daniele , Lenzi Andrea , Isidori Andrea M.

Background: Patients with adrenal incidentalomas and possible autonomous cortisol secretion (pACS) suffer from a high rate of cardiovascular events and mortality. We have previously showed that left ventricular mass index (LVMi) is higher in patients with pACS, compared with patients with non-functioning adenomas (NFA). To date, the management of pACS is still controversial, with a lack of consensus regarding the benefits of surgery.Objectives: This pros...

ea0075a11 | Adrenal gland | EYES2021

Castleman’s Disease resembling an adrenal mass: case report and review of the literature

Angelini Francesco , Minnetti Marianna , Mazzotta Paola , Corallino Diletta , Paganini Alessandro M. , Sbardella Emilia , Gianfrilli Daniele , Isidori Andrea M.

Background: The increase use of abdominal imaging have given rise in incidental discovery of adrenal masses. We report a case of a localized Castleman’s Disease(CD), mimicking an adrenal mass.Case report: A 29-year-old woman was found to have a 6 cm, well-circumscribed and hypoechoic, right adrenal incidentaloma during an abdominopelvic ultrasonography. The CT scan confirmed a suprarenal mass with heterogenous contrast enhancement. Adrenal gland cou...

ea0075d12 | Diabetes | EYES2021

Sex differences in quality of life and sexual function in type 2 diabetes mellitus: results from the RECOGITO trial

Feola Tiziana , Ferrari Davide , Pofi Riccardo , Lecis Claudio , Centello Roberta , Lenzi Andrea , Gianfrilli Daniele , Isidori Andrea M. , Giannetta Elisa

Background: Type 2 diabetes mellitus (T2DM) significantly impacts Health-Related Quality of Life (HRQoL) and sexual function. The aim of this study was to evaluate sex differences in HRQoL and sexual function in patients with T2DM.Methods: We performed an ancillary study of RECOGITO trial (REmodelling in Diabetic CardiOmyopathy: Gender Response to PDE5i InhibiTOrs - NCT01803828). All patients completed the 36-item-Short-Form Health Survey (SF-36), assess...